1. Contraindications of tDCS (skin disease, superficial injury, and fracture or infraction of skull in the stimulation area, epilepsy, metallic plates in the head) 2. History of any other DSM-IV axis I diagnosis prior to COVID-19, except for: 2.1. Depressive disorders, anxiety disorders, and sleep disorders that may be present in the history, but with at least 6 months of documented remission of symptoms 2.2. Disorders associated with the use of addictive substances at least 6 months before entering the study 3. Pregnancy or breastfeeding 4. Patients with severe and/or unstable somatic disorders (cardiovascular disease, neoplasms, endocrinology disorders, etc) 5. Patients suffering from a serious neurological disorder (eg epilepsy, head injury with loss of consciousness)

1. Contraindications of tDCS (skin disease, superficial injury, and fracture or infraction of skull in the stimulation area, epilepsy, metallic plates in the head) 2. History of any other DSM-IV axis I diagnosis prior to COVID-19, except for: 2.1. Depressive disorders, anxiety disorders, and sleep disorders that may be present in the history, but with at least 6 months of documented remission of symptoms 2.2. Disorders associated with the use of addictive substances at least 6 months before entering the study 3. Pregnancy or breastfeeding 4. Patients with severe and/or unstable somatic disorders (cardiovascular disease, neoplasms, endocrinology disorders, etc) 5. Patients suffering from a serious neurological disorder (eg epilepsy, head injury with loss of consciousness)